Navigation Links
Funding Tomorrow's Biomedical Research: California Healthcare Institute Hosts Pipeline for Life, July 15
Date:7/11/2013

LA JOLLA, Calif. (PRWEB) July 11, 2013

WHAT: CHI-California Healthcare Institute is hosting Pipeline for Life: Revitalizing Our Biomedical Research Ecosystem for a Healthier Tomorrow in La Jolla, California. Sequestration is putting enormous pressure on government funding for research programs that form the scientific base for innovative medical advances for patients.

WHO: Top academic leaders and industry executives from: Allergan, Bristol-Myers Squibb, Cedars-Sinai, Bay City Capital, Genzyme, The Scripps Research Institute, J. Gladstone Institutes, Gilead Sciences, Bay City Capital, City of Hope, Thermo Fisher Scientific, Health and policy experts from CHI, University of California, Irvine, University of California, San Diego and more.

WHY: At Pipeline for Life, California Healthcare Institute (CHI) will convene an extraordinary group of biomedical industry leaders and influential policymakers for focused discussions on success in basic research, public policy, modernizing innovation and strategy while reshaping the market for medical innovation and research inspiration for success in new therapies and medical technologies. This event brings together representatives from CHI’s member organizations with policymakers to discuss critical issues and opportunities facing the biomedical community. The goal of the Pipeline for Life is to produce a clearer understanding of the biomedical community’s work and needs, and how the industry can sustain California’s leadership in biomedical research and innovation.

WHO SHOULD ATTEND: Leaders from California’s biomedical industry, academic research community, entrepreneurs, healthcare providers, investors, members of the media, policy experts and patient advocates.

WHEN: Monday, July 15, 2013
Registration: 11:30 a.m. – noon
Welcoming Lunch: noon - 1:10 p.m.
Panel discussions and keynotes: 1:15 – 5:00 p.m.
Reception: 5–6 p.m.

WHERE: The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California

For more information, visit chi.org/events

Media Inquiries & Event Registration:
Erica Hiar
202-974-6322
Hiar(at)chi(dot)org

About CHI
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is http://www.chi.org. Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10918157.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Crowdfunding Expert Kendall Almerico Discusses Crowdfunding for Science
2. SPIE Leaders Commend OMB Support for Travel to Scientific Conferences, Say Funding is Also Needed
3. Pittsburgh Life Sciences Greenhouse Makes Significant Reductions Due to Uncertain Funding
4. NSBRI Industry Forum Launches SMARTCAP-Accel, a Grant Funding Opportunity to Catalyze Development of Products for Spaceflight
5. Patheon to Host Complimentary Seminar on “Formulation, Funding and First-in-Man: A Stepwise Guide to Clinical Success”
6. NIH Saves Lives: Fred Hutchinson Cancer Research Center Calls On Congress To Restore Full NIH Funding
7. Real Time Genomics Secures a $5 Million Round of Funding to Expand Commercial Operations
8. SPIE Encouraged By Increased Science Funding in Obama Budget, Urges Applied Research Emphasis
9. Suspect Detection Systems Receives Funding From Israel-Publicly Traded Biomedix Ltd.
10. BioHealth Innovation, Inc. Launches Program to Help Life Science Companies Navigate Federal Funding Application Process
11. VG Life Sciences, Inc. Secures Two-Year Funding Commitment and Administrative Support from MedBridge, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
Breaking Biology News(10 mins):